Pancreatic tumors have generally been considered as immune-privileged in nature, but accumulation of CD8+ cytotoxic T cells in the tumor is correlated with a better prognosis in PDAC [45,46]. This evidence concerns the gene CD8A and pancreatic neoplasm.